Evidence map›Paper›PMID 31671704›Full record

ArticleCells2019

Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson's Disease-Associated Pathology.

George Edwards Iii, Nazaret Gamez, Enrique Armijo, Carlos Kramm, Rodrigo Morales, Kathleen Taylor-Presse, Paul E Schulz, Claudio Soto, Ines Moreno-Gonzalez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Longitudinal Assessment of Tau-Associated Pathology byDiagnostics (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

George Edwards IiiThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. George.A.Edwards@uth.tmc.edu.
Nazaret GamezThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. Nazaret.GamezRuiz@uth.tmc.edu.
Enrique ArmijoThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. Enrique.Antonio.ArmijoFuentes@uth.tmc.edu.
Carlos KrammThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. Carlos.F.KrammBarria@uth.tmc.edu.
Rodrigo MoralesThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. Rodrigo.MoralesLoyola@uth.tmc.edu.
Kathleen Taylor-PresseThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. TaylorPresse@uth.tmc.edu.
Paul E SchulzThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. Paul.E.Schulz@uth.tmc.edu.
Claudio SotoThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. Claudio.Soto@uth.tmc.edu.
Ines Moreno-GonzalezThe Mitchell Center for Alzheimer's Disease and Related Brain Disorders, Department of Neurology, The University of Texas Houston Health Science Center at Houston, Houston, TX 77030, USA. inesmoreno@uma.es.
The University of Texas Health Science Center at Houston · USUniversidad de Los Andes, Chile · CLUniversidad Bernardo O'Higgins · CLInstituto de Investigación Biomédica de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Nerve Degeneration1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsDisease Models, AnimalEmbryonic Stem CellsFemaleMaleMesenchymal Stem CellsMiceMice, Inbred C57BLNeural Stem CellsNeurotoxinsOxidative StressParkinson DiseaseStem Cell Transplantation1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeurotoxinsclinical symptomsinflammationintravenousneuronal precursorsParkinson’s diseasestem cellstherapy

Identifiers

PMID31671704
PMCPMC6912680
OpenAlexW2982447920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.